Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia

• Sheila Xinxuan Soh,

  Affiliation Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore, Singapore

  ⨯
• Joshua Yew Suang Lim,

  Affiliation Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  ⨯
• John W. J. Huang,

  Affiliation Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore, Singapore

  ⨯
• Nan Jiang,

  Affiliation Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  ⨯
• Allen Eng Juh Yeoh,

  Affiliations Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, National University Cancer Institute, National University Health System, Singapore, Singapore, Viva-University Children's Cancer Centre, University Children's Medical Institute, National University Health System, Singapore, Singapore, Cancer Science Institute, National University of Singapore, Singapore, Singapore

  ⨯
• S. Tiong Ong

  * E-mail: sintiong.ong@duke-nus.edu.sg

  Affiliations Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore, Singapore, Department of Haematology, Singapore General Hospital, Singapore, Singapore, Department of Medical Oncology, National Cancer Centre, Singapore, Singapore, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯